| Version |
2.5 |
| Creation Date |
2005-06-13 13:24:05 |
| Update Date |
2008-08-26 15:45:22 |
| Primary Accession Number |
DB04474 |
| Secondary Accession Number |
|
| Name |
1-Anilino-8-Naphthalene Sulfonate |
| Drug Type |
- Experimental
- Small Molecule
|
| Description |
Not Available |
| Synonyms |
Not Available |
| Brand Names |
Not Available |
| Brand Mixtures |
Not Available |
| Chemical IUPAC Name |
8-(phenylamino)naphthalene-1-sulfonic acid |
| Chemical Formula |
C16H13NO3S |
| Chemical Structure |
 |
| CAS Registry Number |
Not Available |
| InChI Identifier |
InChI=1/C16H13NO3S/c18-21(19,20)15-11-5-7-12-6-4-10-14(16(12)15)17-13-8-2-1-3-9-13/h1-11,17H,(H,18,19,20)/f/h18H |
| InChI Key |
FWEOQOXTVHGIFQ-GPQMBLKYCA |
| KEGG Drug |
Not Available |
| KEGG Compound |
Not Available |
| PubChem Compound |
1369  |
| PubChem Substance |
7885147  |
| ChEBI ID |
Not Available |
| PharmGKB ID |
Not Available |
| HET ID |
2AN  |
| GenBank ID |
Not Available |
| Drug ID Number [DIN] |
Not Available |
| RxList Link |
Not Available |
| PDRhealth Link |
Not Available |
| Wikipedia Link |
Not Available |
| FDA Label |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available |
| Synthesis Reference |
Not Available |
| Average Molecular Weight |
299.3440 |
| Monoisotopic Molecular Weight |
299.0616 |
| State |
Solid |
| Melting Point |
Not Available |
| Experimental Water Solubility |
Not Available
Source: PhysProp
|
| Predicted Water Solubility |
1.51e-02 mg/mL
Calculated using ALOGPS
|
| Experimental LogP/Hydrophobicity |
Not Available
Source: PhysProp
|
| Predicted LogP |
1.55
Calculated using ALOGPS
|
| Experimental LogS |
Not Available |
| Predicted LogS |
-4.30
Calculated using ALOGPS
|
| Experimental Caco2 Permeability |
Not Available |
| pKa/Isoelectric Point |
Not Available |
| Mass Spectrum |
Not Available
|
| MOL File |
Show | Download  |
| SDF File |
Show | Download  |
| PDB File |
Show | Download  |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
1OW4  |
| Experimental PDB File |
Show |
| Experimental PDB Structure |
|
| Isomeric SMILES |
OS(=O)(=O)C1=CC=CC2=C1C(NC1=CC=CC=C1)=CC=C2 |
| Canonical SMILES |
OS(=O)(=O)C1=CC=CC2=C1C(NC1=CC=CC=C1)=CC=C2 |
| Drug Category |
|
| ATC Codes |
Not Available |
| AHFS Codes |
Not Available |
| Indication |
Not Available |
| Pharmacology |
Not Available |
| Mechanism of Action |
Not Available |
| Absorption |
Not Available |
| Toxicity |
Not Available |
| Protein Binding |
Not Available |
| Biotransformation |
Not Available |
| Half Life |
Not Available |
| Dosage Forms |
Not Available
|
| Patient Information |
Not Available |
| Contraindications |
Not Available |
| Interactions |
Not Available |
| Drug Interactions |
Not Available
|
| Food Interactions |
Not Available
|
| Pathways |
Not Available
|
| General References |
Not Available |
| Organisms Affected |
Not Available |
| Targets |
- UDP-N-acetylglucosamine 1-carboxyvinyltransferase
- Fatty acid-binding protein, adipocyte
- Pheromone binding protein
|
|
Drug Target 1
[top]
|
| Target 1 ID |
2367 |
| Target 1 Name |
UDP-N-acetylglucosamine 1-carboxyvinyltransferase |
| Target 1 Synonyms |
- EC 2.5.1.7
- EPT
- Enoylpyruvate transferase
- UDP-N-acetylglucosamine enolpyruvyl transferase
|
| Target 1 Gene Name |
murA |
| Target 1 Protein Sequence |
>UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MDKFRVQGPTRLQGEVTISGAKNAALPILFAALLAEEPVEIQNVPKLKDIDTTMKLLTQL
GTKVERNGSVWIDASNVNNFSAPYDLVKTMRASIWALGPLVARFGQGQVSLPGGCAIGAR
PVDLHIFGLEKLGAEIKLEEGYVKASVNGRLKGAHIVMDKVSVGATVTIMSAATLAEGTT
IIENAAREPEIVDTANFLVALGAKISGQGTDRITIEGVERLGGGVYRVLPDRIETGTFLV
AAAISGGKIVCRNAQPDTLDAVLAKLREAGADIETGEDWISLDMHGKRPKAVTVRTAPHP
AFPTDMQAQFTLLNLVAEGTGVITETIFENRFMHVPELIRMGAHAEIESNTVICHGVEKL
SGAQVMATDLRASASLVLAGCIAEGTTVVDRIYHIDRGYERIEDKLRALGANIERVKGE
|
| Target 1 Number of Residues |
425 |
| Target 1 Molecular Weight |
44777 |
| Target 1 Theoretical pI |
5.92 |
| Target 1 GO Classification |
|
Function
|
catalytic activity
transferase activity |
|
Process
|
physiological process
metabolism
nitrogen compound metabolism
amine metabolism
amino sugar metabolism
UDP-N-acetylgalactosamine metabolism
UDP-N-acetylgalactosamine biosynthesis |
|
Component
|
| Not Available |
|
| Target 1 General Function |
Cell wall/membrane/envelope biogenesis |
| Target 1 Specific Function |
Cell wall formation. Adds enolpyruvyl to UDP-N- acetylglucosamine. Target for the antibiotic phosphomycin |
| Target 1 Pathways |
| Name |
SMPDB Link |
KEGG Link |
| Aminosugars metabolism |
|
map00530  |
|
| Target 1 Reactions |
- phosphoenolpyruvate + UDP-N-acetyl-D-glucosamine = phosphate + UDP-N-acetyl-3-O-(1-carboxyvinyl)-D-glucosamine
|
| Target 1 Pfam Domain Function |
|
| Target 1 Signals |
|
| Target 1 Transmembrane Regions |
|
| Target 1 Essentiality |
Essential |
| Target 1 GenBank ID Protein |
41344  |
| Target 1 UniProtKB/Swiss-Prot ID |
P33038  |
| Target 1 UniProtKB/Swiss-Prot Entry Name |
MURA_ENTCL  |
| Target 1 PDB ID |
1NAW  |
| Target 1 PDB File |
Show |
| Target 1 3D Structure |
|
| Target 1 Cellular Location |
|
| Target 1 Gene Sequence |
>1260 bp
ATGGATAAATTTCGTGTACAGGGGCCGACGCGCCTCCAGGGCGAAGTCACAATTTCTGGC
GCGAAAAACGCCGCGCTGCCGATCCTCTTTGCTGCGCTGCTCGCGGAAGAGCCGGTAGAA
ATTCAGAACGTACCGAAGCTGAAAGATATCGACACCACCATGAAGCTGCTCACCCAGTTG
GGGACGAAAGTCGAGCGTAATGGCTCCGTCTGGATCGATGCCAGCAACGTGAACAACTTC
TCAGCACCGTACGACCTGGTGAAAACCATGCGTGCATCCATCTGGGCGCTTGGCCCGCTG
GTAGCGCGTTTTGGTCAGGGACAGGTGTCACTGCCTGGTGGTTGCGCCATTGGCGCGCGT
CCTGTTGACCTGCATATCTTCGGTCTGGAGAAGCTGGGCGCGGAGATCAAACTGGAAGAA
GGTTACGTTAAAGCGTCCGTTAATGGCCGCCTGAAAGGCGCACACATTGTCATGGATAAA
GTGAGCGTTGGCGCAACCGTCACCATTATGTCCGCGGCAACGCTGGCAGAAGGTACCACC
ATTATCGAAAACGCCGCGCGCGAGCCGGAAATTGTGGATACTGCCAACTTCCTCGTGGCG
CTGGGTGCAAAAATCTCTGGCCAGGGTACCGATCGCATCACCATTGAAGGCGTTGAGCGT
CTGGGGGGCGGTGTGTATCGCGTTCTGCCAGACCGTATTGAAACCGGGACTTTCCTGGTG
GCTGCGGCCATTTCTGGCGGCAAGATTGTTTGCCGTAATGCGCAGCCTGACACCCTGGAT
GCGGTGCTGGCGAAGCTGCGTGAAGCGGGTGCGGATATCGAAACCGGTGAAGACTGGATC
AGCCTTGATATGCACGGTAAACGTCCAAAAGCGGTAACCGTTCGCACGGCGCCGCATCCG
GCATTCCCGACCGATATGCAGGCTCAGTTCACGCTGCTGAACCTGGTGGCAGAAGGTACC
GGTGTGATCACCGAGACTATCTTCGAGAACCGCTTCATGCACGTACCGGAGCTGATCCGT
ATGGGCGCACATGCAGAGATCGAAAGTAACACGGTGATTTGCCACGGTGTTGAGAAGCTC
TCCGGTGCGCAGGTTATGGCAACCGATCTGCGTGCGTCTGCGAGCCTGGTATTAGCGGGT
TGTATCGCGGAAGGAACGACGGTTGTGGATCGTATCTACCACATCGATCGTGGTTACGAG
CGTATTGAAGACAAACTGCGCGCGCTGGGTGCCAATATCGAGCGTGTGAAGGGCGAGTAA
|
| Target 1 GenBank Gene ID |
|
| Target 1 GeneCard ID |
Not Available |
| Target 1 GenAtlas ID |
Not Available |
| Target 1 HGNC ID |
Not Available |
| Target 1 Chromosome Location |
Not Available |
| Target 1 Locus |
Not Available |
| Target 1 SNPs |
SNPJam Report  |
| Target 1 General References |
- Schonbrunn E, Eschenburg S, Krekel F, Luger K, Amrhein N: Role of the loop containing residue 115 in the induced-fit mechanism of the bacterial cell wall biosynthetic enzyme MurA. Biochemistry. 2000 Mar 7;39(9):2164-73. [PubMed
]
- Wanke C, Falchetto R, Amrhein N: The UDP-N-acetylglucosamine 1-carboxyvinyl-transferase of Enterobacter cloacae. Molecular cloning, sequencing of the gene and overexpression of the enzyme. FEBS Lett. 1992 Apr 27;301(3):271-6. [PubMed
]
- Schonbrunn E, Sack S, Eschenburg S, Perrakis A, Krekel F, Amrhein N, Mandelkow E: Crystal structure of UDP-N-acetylglucosamine enolpyruvyltransferase, the target of the antibiotic fosfomycin. Structure. 1996 Sep 15;4(9):1065-75. [PubMed
]
|
| Target 1 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 2
[top]
|
| Target 2 ID |
2855 |
| Target 2 Name |
Fatty acid-binding protein, adipocyte |
| Target 2 Synonyms |
- 3T3-L1 lipid-binding protein
- 422 protein
- A-FABP
- AFABP
- ALBP
- Adipocyte lipid-binding protein
- Myelin P2 protein homolog
- P15
- P2 adipocyte protein
|
| Target 2 Gene Name |
Fabp4 |
| Target 2 Protein Sequence |
>Fatty acid-binding protein, adipocyte
MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKN
TEISFKLGVEFDEITADDRKVKSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVM
KGVTSTRVYERA
|
| Target 2 Number of Residues |
134 |
| Target 2 Molecular Weight |
14650 |
| Target 2 Theoretical pI |
8.71 |
| Target 2 GO Classification |
|
Function
|
lipid binding
binding |
|
Process
|
physiological process
cellular physiological process
transport |
|
Component
|
| Not Available |
|
| Target 2 General Function |
Involved in fatty acid binding |
| Target 2 Specific Function |
Lipid transport protein in adipocytes. Binds both long chain fatty acid and retinoic acid |
| Target 2 Pathways |
Not Available
|
| Target 2 Reactions |
Not Available |
| Target 2 Pfam Domain Function |
|
| Target 2 Signals |
|
| Target 2 Transmembrane Regions |
|
| Target 2 Essentiality |
Essential |
| Target 2 GenBank ID Protein |
293695  |
| Target 2 UniProtKB/Swiss-Prot ID |
P04117  |
| Target 2 UniProtKB/Swiss-Prot Entry Name |
FABPA_MOUSE  |
| Target 2 PDB ID |
2ANS  |
| Target 2 PDB File |
Show |
| Target 2 3D Structure |
|
| Target 2 Cellular Location |
|
| Target 2 Gene Sequence |
>399 bp
ATGTGTGATGCCTTTGTGGGAACCTGGAAGCTTGTCTCCAGTGAAAACTTCGATGATTAC
ATGAAAGAAGTGGGAGTGGGCTTTGCCACAAGGAAAGTGGCAGGCATGGCCAAGCCCAAC
ATGATCATCAGCGTAAATGGGGATTTGGTCACCATCCGGTCAGAGAGTACTTTTAAAAAC
ACCGAGATTTCCTTCAAACTGGGCGTGGAATTCGATGAAATCACCGCAGACGACAGGAAG
GTGAAGAGCATCATAACCCTAGATGGCGGGGCCCTGGTGCAGGTGCAGAAGTGGGATGGA
AAGTCGACCACAATAAAGAGAAAACGAGATGGTGACAAGCTGGTGGTGGAATGTGTTATG
AAAGGCGTGACTTCCACAAGAGTTTATGAAAGGGCATGA
|
| Target 2 GenBank Gene ID |
|
| Target 2 GeneCard ID |
Not Available |
| Target 2 GenAtlas ID |
Not Available |
| Target 2 HGNC ID |
Not Available |
| Target 2 Chromosome Location |
Not Available |
| Target 2 Locus |
Not Available |
| Target 2 SNPs |
SNPJam Report  |
| Target 2 General References |
- Xu Z, Bernlohr DA, Banaszak LJ: Crystal structure of recombinant murine adipocyte lipid-binding protein. Biochemistry. 1992 Apr 7;31(13):3484-92. [PubMed
]
- Cook JS, Lucas JJ, Sibley E, Bolanowski MA, Christy RJ, Kelly TJ, Lane MD: Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP. Proc Natl Acad Sci U S A. 1988 May;85(9):2949-53. [PubMed
]
- Matarese V, Bernlohr DA: Purification of murine adipocyte lipid-binding protein. Characterization as a fatty acid- and retinoic acid-binding protein. J Biol Chem. 1988 Oct 5;263(28):14544-51. [PubMed
]
- Phillips M, Djian P, Green H: The nucleotide sequence of three genes participating in the adipose differentiation of 3T3 cells. J Biol Chem. 1986 Aug 15;261(23):10821-7. [PubMed
]
- Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM: Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3786-90. [PubMed
]
- Cook KS, Hunt CR, Spiegelman BM: Developmentally regulated mRNAs in 3T3-adipocytes: analysis of transcriptional control. J Cell Biol. 1985 Feb;100(2):514-20. [PubMed
]
- Bernlohr DA, Angus CW, Lane MD, Bolanowski MA, Kelly TJ Jr: Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5468-72. [PubMed
]
- Bansal MP, Medina D: Expression of fatty acid-binding proteins in the developing mouse mammary gland. Biochem Biophys Res Commun. 1993 Feb 26;191(1):61-9. [PubMed
]
- Xu Z, Bernlohr DA, Banaszak LJ: The adipocyte lipid-binding protein at 1.6-A resolution. Crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids. J Biol Chem. 1993 Apr 15;268(11):7874-84. [PubMed
]
|
| Target 2 Drug References |
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed
]
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed
]
|
|
Drug Target 3
[top]
|
| Target 3 ID |
4822 |
| Target 3 Name |
Pheromone binding protein |
| Target 3 Synonyms |
Not Available |
| Target 3 Gene Name |
Not Available |
| Target 3 Protein Sequence |
>Pheromone binding protein
MRSLQLTCLLAVATATLADSTQSYKDAMGPLVRECMGSVSATEDDFKTVLNRNPLESRTA
QCLLACALDKVGLISPEGAIYTGDDLMPVMNRLYGFNDFKTVMKAKAVNDCANQVNGAYP
DRCDLIKNFTDCVRNSY
|
| Target 3 Number of Residues |
139 |
| Target 3 Molecular Weight |
14975 |
| Target 3 Theoretical pI |
4.82 |
| Target 3 GO Classification |
|
Function
|
binding
odorant binding |
|
Process
|
physiological process
cellular physiological process
transport |
|
Component
|
| Not Available |
|
| Target 3 General Function |
Involved in odorant binding |
| Target 3 Specific Function |
Not Available |
| Target 3 Pathways |
Not Available
|
| Target 3 Reactions |
Not Available |
| Target 3 Pfam Domain Function |
|
| Target 3 Signals |
|
| Target 3 Transmembrane Regions |
|
| Target 3 Essentiality |
Essential |
| Target 3 GenBank ID Protein |
Not Available |
| Target 3 UniProtKB/Swiss-Prot ID |
Q8MTC1  |
| Target 3 UniProtKB/Swiss-Prot Entry Name |
Q8MTC1_LEUMA  |
| Target 3 PDB ID |
1P28  |
| Target 3 PDB File |
Show |
| Target 3 3D Structure |
|
| Target 3 Cellular Location |
Not Available |
| Target 3 Gene Sequence |
>414 bp
ATGCGGTCTCTGCAACTAACCTGTTTGCTAGCAGTAGCTACAGCCACTCTGGCGGACTCT
ACCCAGAGCTACAAGGACGCTATGGGGCCGCTGGTAAGAGAGTGCATGGGCAGTGTCTCT
GCCACTGAAGACGACTTCAAAACGGTTTTGAACAGGAACCCTCTGGAATCAAGGACAGCT
CAGTGTTTGCTAGCCTGCGCCCTGGACAAGGTGGGCCTTATCTCACCAGAAGGCGCCATC
TATACAGGAGATGACCTGATGCCTGTCATGAACCGACTGTACGGTTTCAACGACTTCAAG
ACAGTCATGAAGGCCAAGGCCGTGAACGACTGCGCCAATCAAGTGAACGGTGCGTATCCG
GACAGGTGTGATCTTATCAAGAACTTCACCGATTGCGTCCGCAACTCCTACTGA
|
| Target 3 GenBank Gene ID |
|
| Target 3 GeneCard ID |
Not Available |
| Target 3 GenAtlas ID |
Not Available |
| Target 3 HGNC ID |
Not Available |
| Target 3 Chromosome Location |
Not Available |
| Target 3 Locus |
Not Available |
| Target 3 SNPs |
Not Available |
| Target 3 General References |
Not Available |
| Target 3 Drug References |
Not Available |